Presynaptic α-2C adrenoceptor-mediated control of noradrenaline release in humans: Genotype- or age-dependent?

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 5, 2007, Pages 525-530

  Bruck, H ^a   Schwerdtfeger, T ^a   Toliat, M ^b   Leineweber, K ^a   Heusch, G ^a   Philipp, T ^a   Nurnberg P ^b   Brodde, O E ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; CLONIDINE; NORADRENALIN; PRESYNAPTIC RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HEART RATE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGING; BLOOD PRESSURE; CLONIDINE; FEMALE; GENOTYPE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NOREPINEPHRINE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 35448956149     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100181     Document Type: Article

References (39)

1. Starke, K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1-124 (1977).
2. Langer, S.Z. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 132, 337-362 (1981).
3. 2-receptors. J. Mol. Cell Cardiol. 15, 717-733 (1983).
4. Brodde, O.-E. & Michel, M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacol. Rev. 51, 651-689 (1999).
5. 2-Adrenergic receptor subtypes - novel functions uncovered by gene-targeted mouse models. Biol. Cell 96, 343-348 (2004).
6. Philipp, M. & Hein, L. Adrenergic receptor knockout mice: distinct functions of 9 adrenergic receptor subtypes. Pharmacol. Ther. 101, 65-74 (2004).
7. Small, K.M. & Liggett, S.B. Identification and functional characterization of α2adrenoceptor polymorphisms. Trends Pharmacol. Sci. 22, 471-477 (2001).
8. 2C-adrenergic receptor confers impaired coupling to multiple effects. J. Biol. Chem. 275, 23059-23064 (2000).
9. Port, J.D. & Bristow, M.R. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J. Mol. Cell Cardiol. 33, 887-905 (2001).
10. 2C- adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med. 347, 1135-1142 (2002).
11. Nonen, S. et al. No positive association between adrenergic receptor variants of α2CDel322-325, β1Ser49, β1Arg389 and the risk of heart failure in the Japanese population. Br. J. Clin. Pharmacol. 60, 414-417 (2006).
12. Metra, M. et al. Role of β1- and α2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur. J. Heart Fail. 8, 131-135 (2006).
13. 1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume. J. Am. Coll. Cardiol. 49, 274-276 (2007).
14. Bravo, E.L., Tarazi, R.C., Fouad, F.M., Vidt, D.G. & Gifford, R.W. Clondine-suppression-test: a useful aid in the diagnosis of pheochromocytoma. N. Engl. J. Med. 305, 623-626 (1981).
15. Kobinger, W. Central alpha-adrenergic system as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol. 81, 39-100 (1978).
16. Kaye, D.M., Smirk, B., Finch, S., Williams, C. & Esler, M.D. Interaction between cardiac sympathetic drive and heart rate in heart failure. J. Am. Coll. Cardiol. 44, 2008-2015 (2004).
17. Kirstein, S.L. & Insel, P.A. Autonomic nervous system pharmacogenomics: a progress report. Pharmacol. Rev. 56, 31-52 (2004).
18. 2C adrenergic receptors predispose to hypertension in blacks? Hypertension 47, 1140-1146 (2006).
19. Aggrawal, A., Esler, M.D., Socratous, F. & Kaye, D.M. Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. J. Am. Coll. Cardiol. 37, 1246-1251 (2001).
20. 2C-Adrenoceptor-modulated release of noradrenaline in human right atrium. Br. J. Pharmacol. 116, 2617-2624 (1995).
21. 2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenet. and Genomics 15, 143-149 (2005).
22. 3H]dihydroergocryptine on intact human platelets. Br. J. Pharmacol. 76, 121-130 (1982).
23. Jones, S.B., Bylund, D.B., Rieser, C.A., Shekim, W.O., Byer, J.A. & Carr, G.W. Alpha 2-adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin. Pharmacol. Ther. 34, 90-96 (1983).
24. Motulsky, H.J., O'Connor, D.T. & Insel, P.A. Platelet alpha-2-adrenergic receptors in treated and untreated essential hypertension. Clin. Sci. 64, 265-272 (1983).
25. 3H]dihydroergocryptine. J. Clin. Invest. 74, 1063-1072 (1984).
26. Buckley, C., Curtin, D., Walsh, T. & O'Malley, K. Ageing and platelet alpha-2 adrenoceptors. Br. J. Clin. Pharmacol. 21, 721-722 (1986).
27. Davis, P.B. & Silski, C. Ageing and the alpha 2-adrenergic system of the platelet. Clin. Sci. 73, 507-513 (1987).
28. 2-adrenergic receptor number in human platelets. Eur. J. Pharmacol. 81, 345-347 (1982).
29. Supiano, M.A., Linares, O.A., Halter, J.B., Reno, K.M. & Rosen, S.G. Functional uncoupling of the platelet alpha 2-adrenergic receptoradenylate cyclase complex in the elderly. J. Clin. Endocrinol. Metab. 64, 1160-1164 (1987).
30. Supiano, M.A., Neubig, R.R., Linares, O.A., Halter, J.B. & Rosen, S.G. Effects of low sodium diet on regulation of platelet α2-adrenergic receptors in young and elderly humans. Am. J. Physiol. Endocrinol. Metab. 256, E339-E344 (1989).
31. Bursztyn, M., Bresnahan, M., Gavras, I. & Gavras, H. Effect of aging on vasopressin, catecholamines, and alpha-2 adrenergic receptors. J. Am. Geriatr. Soc. 38, 628-632 (1990).
32. Supiano, M.A. & Hogikyan, R.V. High affinity platelet alpha 2-adrenergic receptor density is decreased in older humans. J. Gerontol. 48, B173-B179 (1993).
33. Yokoyama, M., Kusui, A., Sakamoto, S. & Fukuzaki, H. Age-associated increments in human platelet alpha-adrenoceptor capacity. Possible mechanism for platelet hyperactivity to epinephrine in aging man. Thromb. Res. 15, 287-295 (1984).
34. Featherstone, J.A., Veith, R.C., Flatness, D., Murburg, M.M., Villacres, E.C. & Halter, J.B. Age and alpha-2 adrenergic regulation of plasma norepinephrine kinetics in humans. J. Gerontol. 42, 271-276 (1987).
35. Klein, C.E., Gerber, J.G. & Nies, A.S. Lack of an effect of age on the response to clonidine. Clin. Pharmacol. Ther. 47, 61-67 (1990).
36. Petrie, E.C., Peskind, E.R., Dobie, D.J., Veith, R.C. & Raskind, M.A. Increased plasma norepinephrine response to yohimbine in elderly men. J. Gerontol. Med. Sci. 55A, M155-M159 (2000).
37. Poller, U., Nedelka, G., Radke, J., Pönicke, K. & Brodde, O.-E. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J. Am. Coll. Cardiol. 29, 187-193 (1997).
38. Brodde, O.-E. et al. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J. Clin. Invest. 101, 471-478 (1998).
39. 1-adrenoceptor polymorphism in humans. Pharmacogenetics 11, 199-205 (2001).